Labor augmentation with oxytocin in low- and lower-middle-income countries: a systematic review and meta-analysis.

ABSTRACT:

Objective

Despite its worldwide use, reviews of oxytocin for labor augmentation include mainly studies from high-income countries. Meanwhile, oxytocin is a potentially harmful medication and risks may be higher in low-resource settings. We conducted a systematic review and meta-analysis of practices, benefits, and risks of oxytocin for labor augmentation in low- and lower-middle-income countries.

Data sources

PubMed, Embase, PsycINFO, Index Medicus, Cochrane, and Google Scholar were searched for publications until January 1, 2022.

Study eligibility criteria

All studies evaluating oxytocin augmentation rates were included. To investigate benefits and risks, randomized and quasi-randomized trials comparing oxytocin augmentation with placebo or no oxytocin were included.

SUBMITTER: Kujabi ML 

PROVIDER: S-EPMC9664020 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature